Beg Z H, Stonik J A, Brewer H B
Metabolism. 1987 Sep;36(9):900-17. doi: 10.1016/0026-0495(87)90101-6.
This report summarizes the current concepts regarding the in vitro and in vivo modulation of the enzymic activity of HMG-CoA reductase and mevalonate formation in rat and human liver, as well as in cultured fibroblasts from normal and familial hypercholesterolemic subjects. Three separate mechanisms for the short-term modulation of hepatic HMG-CoA reductase activity by covalent phosphorylation have been described. These mechanisms involved three separate specific kinase systems including reductase kinase, protein kinase C, and a Ca+2, calmodulin-dependent kinase. The conceptual schemes presented in this report will provide a basis for future research as well as an overview for improved understanding of the complex and multifaceted short-term regulation of this key enzyme in the biosynthetic pathways of mevalonate, ubiquinones, dolichols, isopentenyl-tRNAs, and cholesterol.
本报告总结了目前关于大鼠和人肝脏以及正常和家族性高胆固醇血症患者培养成纤维细胞中HMG-CoA还原酶的酶活性和甲羟戊酸形成的体外和体内调节的概念。已经描述了通过共价磷酸化对肝脏HMG-CoA还原酶活性进行短期调节的三种不同机制。这些机制涉及三种不同的特异性激酶系统,包括还原酶激酶、蛋白激酶C和一种Ca+2、钙调蛋白依赖性激酶。本报告中提出的概念性方案将为未来的研究提供基础,并为更好地理解甲羟戊酸、泛醌、多萜醇、异戊烯基-tRNA和胆固醇生物合成途径中这一关键酶的复杂多方面短期调节提供概述。